The Ott Lab publishes novel research on SARS-CoV-2 variants Read More

Ott Lab News

Fall’s COVID Shots May Be Different in One Key Way
The Atlantic — This year’s might include XBB.1 and … perhaps no other strain. This fall, millions of Americans might be lining up for yet another kind of COVID vaccine: their first-ever dose that lacks the strain that ignited the pandemic more than three and a half years ago. Unlike the current, bivalent ...
InvisiShield Technologies Collaborates with Gladstone Institutes to Accelerate Development of Intranasal Preventatives against SARS-CoV-2, Influenza, and RSV
Yahoo Finance — InvisiShield Technologies Ltd., a pre-clinical-stage biotechnology company focused on developing intranasal preventives for major disease-causing respiratory viruses, today announced a collaboration with Gladstone Institutes to develop intranasal preventatives against airborne infection, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Gladstone Institutes, a non-profit biomedical research organization that uses visionary science ...
Tips from Virologists to Face the “Tripledemic” This Holiday Season
Gladstone Institutes — As we approach the height of the holiday season, some medical experts have warned of a potential “tripledemic”—a simultaneous surge in cases of COVID-19, the flu, and RSV (respiratory syncytial virus). How concerned should you be, and what does this mean for your holiday plans? We asked three Gladstone virologists—Senior ...
Medical Milestones are Underway at San Francisco’s Gladstone Institutes
Nob Hill Gazette — When California shut down in March 2020 and many San Franciscans stayed at home, obsessively ordering hand sanitizer, a group of local scientists pivoted from the projects they were working on and poured all their energy into COVID-19. Jennifer Doudna, PhD, and Melanie Ott, MD, PhD, developed a new testing ...
Here’s What You Should Know about Monkeypox
Gladstone Institutes — While the world continues to deal with the COVID-19 pandemic, MPXV has emerged as another global public health emergency. Commonly referred to as monkeypox, this viral disease has now spread to dozens of countries where it is not typically found. As of August 29, 2022, over 18,000 cases have been ...
Researchers find SARS-CoV-2 antibodies less effective against Omicron
Daily Cal — Researchers at UC Berkeley, the Gladstone Institutes and the Innovative Genomics Institute discovered that the antibodies generated against SARS-CoV-2 and its variants are less effective against the omicron variant. The omicron variant was first detected in South Africa in late 2021, according to Abdullah Syed, the first author and a ...